v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Successor Successor Predecessor
Current Assets:          
Cash $ 5,902,199 $ 5,902,199 $ 1,278,073 $ 5,902,199  
Prepaid expenses and other current assets 225,347 225,347 1,321,551 225,347  
Vendor deposits 235,000 235,000 235,000 235,000  
Total Current Assets 6,362,546 6,362,546 2,834,624 6,362,546  
Equipment, net 17,333 17,333 14,733 17,333  
In-process research and development 100,086,329 100,086,329 100,086,329 100,086,329  
Goodwill 11,895,033 11,895,033 11,895,033 11,895,033  
Security deposit 46,659 46,659 46,659 46,659  
Operating lease right-of-use asset 98,371 98,371 76,324 98,371  
Vendor deposit    
Total Assets 118,506,271 118,506,271 114,953,702 118,506,271  
Current Liabilities:          
Accounts payable 6,025,645 6,025,645 6,381,086 6,025,645  
Accrued expenses and other current liabilities 2,053,559 2,053,559 2,112,812 2,053,559  
Operating lease liability 108,756 108,756 84,507 108,756  
Derivative liabilities   $ 560,600
Convertible notes payable (net of $0 and $39,942 debt discount as of December 31, 2022 and 2021, respectively)    
Convertible notes payable related parties    
Total Current Liabilities 8,187,960 8,187,960 8,578,405 8,187,960  
Deferred tax liability 10,323,983 10,323,983 9,276,932 10,323,983  
Total Liabilities 18,511,943 18,511,943 17,855,337 18,511,943  
Commitments and contingencies (Note 10)  
Redeemable Common Stock, subject to possible redemption 331,331 331,331 331,331  
Stockholders’ Equity (Deficiency):          
Common stock, value 902 902 922 902  
Additional paid-in-capital 104,583,271 104,583,271 105,562,569 104,583,271  
Accumulated deficit (4,921,178) (4,921,178) (8,465,128) (4,921,178)  
Total Stockholders’ Equity (Deficiency) 99,662,997 99,662,997 97,098,365 99,662,997  
Total Liabilities, Temporary Equity and Stockholders’ Equity (Deficiency) 118,506,271 118,506,271 114,953,702 118,506,271  
Predecessor [Member]          
Financial Designation, Predecessor and Successor [Fixed List]         Predecessor
Current Assets:          
Cash         $ 328,581
Prepaid expenses and other current assets         106,929
Vendor deposits         376,272
Total Current Assets         811,782
Equipment, net         27,733
In-process research and development        
Goodwill        
Security deposit         46,659
Operating lease right-of-use asset        
Vendor deposit         240,000
Total Assets         1,126,174
Current Liabilities:          
Accounts payable         2,000,100
Accrued expenses and other current liabilities         1,914,101
Operating lease liability        
Derivative liabilities         560,600
Convertible notes payable (net of $0 and $39,942 debt discount as of December 31, 2022 and 2021, respectively)         5,976,508
Convertible notes payable related parties         3,175,000
Total Current Liabilities         13,626,309
Deferred tax liability        
Total Liabilities         13,626,309
Commitments and contingencies (Note 10)        
Redeemable Common Stock, subject to possible redemption         331,331
Stockholders’ Equity (Deficiency):          
Common stock, value         242
Additional paid-in-capital         40,065,109
Accumulated deficit         (52,896,817)
Total Stockholders’ Equity (Deficiency)         (12,831,466)
Total Liabilities, Temporary Equity and Stockholders’ Equity (Deficiency)         1,126,174
Series A Preferred Stock [Member]          
Stockholders’ Equity (Deficiency):          
Preferred stock, value 1 1 1 1  
Series A Preferred Stock [Member] | Predecessor [Member]          
Stockholders’ Equity (Deficiency):          
Preferred stock, value        
Series B Preferred Stock [Member]          
Stockholders’ Equity (Deficiency):          
Preferred stock, value $ 1 $ 1 $ 1 $ 1